Draw
|
Currency :
Structure Search
AG005AHX
75695-93-1 | Isradipine
AG005AHX
SDS
COA
Add to Cart
Request For Quotation
- mg
- g
- kg
- ml
- L
无数据
无数据
- mg
- g
- kg
- ml
- L
无数据
| CAS Number | 75695-93-1 |
| Catalog Number | AG005AHX(AGN-PC-00NXL2) |
| Chemical Name | Isradipine |
| IUPAC Name | 3-O-methyl 5-O-propan-2-yl 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate |
| InChI | InChI=1S/C19H21N3O5/c1-9(2)26-19(24)15-11(4)20-10(3)14(18(23)25-5)16(15)12-7-6-8-13-17(12)22-27-21-13/h6-9,16,20H,1-5H3 |
| InChI Key | HMJIYCCIJYRONP-UHFFFAOYSA-N |
| MDL Number | MFCD00153820 |
| Molecular Formula | C19H21N3O5 |
| Molecular Weight | 371.3871 |
| NSC Number | 759892 |
| SMILES | CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)c2cccc3c2non3)C(=O)OC |
| Synonyms | Dynacirc,
Isradipine,
Isradipine, (+-)-Isomer,
Isradipine, (R)-Isomer,
Isradipine, (S)-Isomer,
Lomir,
PN 200-110,
PN 205 033,
PN 205 034,
PN 205-033,
PN 205-034,
PN 205033,
PN 205034,
PN-200-110,
PN-205-033,
PN-205-034,
PN205033,
PN205034,
isradipine,
75695-93-1,
DynaCirc,
Isradipin,
Lomir,
Isrodipine,
Prescal,
Esradin,
Dynacirc CR,
Clivoten,
Dynacrine,
Isradipinum [Latin],
Isradipino [Spanish],
Isradipino,
Isradipinum,
Rebriden,
DynaCire,
PN-200-110,
DynaCire CR,
PN 200-110,
(+-)-Isradipine,
(+/-)-Isradipine,
Isradipine (Dynacirc),
PN 200,
Isradipine(Dynacirc),
MFCD00153820,
3,5-Pyridinedicarboxylic acid, 4-(4-benzofurazanyl)-1,4-dihydro-2,6-dimethyl-, methyl 1-methylethyl ester,
3,5-Pyridinedicarboxylic acid, 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-, methyl 1-methylethyl ester,
HMJIYCCIJYRONP-UHFFFAOYSA-N,
C19H21N3O5,
Isopropyl methyl (+-)-4-(4-benzofurazanyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate,
DSSTox_CID_3179,
DSSTox_RID_76907,
DSSTox_GSID_23179,
3-isopropyl 5-methyl 4-(benzo[c][1,2,5]oxadiazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate,
3-O-methyl 5-O-propan-2-yl 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate,
4-(4-Benzofurazanyl)-1,-4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid methyl 1-methylethyl ester,
4-(4-Benzofurazanyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid methyl 1-methylethyl ester,
O5-methyl O3-propan-2-yl 4-(2,1,3-benzoxadiazol-7-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate,
(+)-isradipine,
Icaz,
Isradipine, (+-)-Isomer,
3,5-Pyridinedicarboxylic acid, 4-(4-benzofurazanyl)-1,4-dihydro-2,6-dimethyl-, methyl 1-methylethyl ester, (+-)-,
SMR000466320,
SMR002529690,
DynaCirc (TN),
Isradipine [USAN:INN:BAN],
Isradipine (USP/INN),
SR-01000597526,
PN 205-033,
PN 205-034,
PN-205-033,
PN-205-034,
Isradipine [USAN:USP:INN:BAN],
NCGC00016931-01,
(-)-Isradipine,
(plusmn)-isradipine,
CAS-75695-93-1,
Spectrum_000218,
PN-200110,
AC1L1GPE,
Prestwick0_001021,
Prestwick1_001021,
Prestwick2_001021,
Prestwick3_001021,
(.+/-.)-Isradipine,
CHEMBL1648,
SCHEMBL34555,
BSPBio_001201,
KBioSS_000698,
MLS000759425,
MLS001424076,
MLS002154106,
MLS003915633,
MLS006010138,
SPBio_003062,
AC1Q426L,
BPBio1_001323,
CHEBI:6073,
CHEMBL315436,
GTPL4488,
CHEMBL3211306,
DTXSID4023179,
CTK8G0407,
KBio2_000698,
KBio2_003266,
KBio2_005834,
AOB5974,
2,1,3-Benzoxadiazole, 3,5-pyridinedicarboxylic acid deriv.,
HMS1571M03,
HMS2051J12,
HMS2098M03,
HMS2235O12,
HMS3268D21,
HMS3393J12,
HMS3655C17,
HMS3677A15,
HMS3715M03,
Pharmakon1600-02300234,
(non-Isotopelabelled)Isradipine-d7,
ACT02697,
BCP06719,
HY-B0233,
Benzo[1,2,5]oxadiazol-4-aldehyde,
Tox21_110690,
BDBM50436176,
BG0371,
CI0041,
NSC759892,
s1662,
AKOS015895129,
Isradipine, >=98% (HPLC), solid,
Tox21_110690_1,
AC-8539,
AN-7921,
API0003052,
CCG-101027,
CCG-213711,
CS-2201,
DB00270,
HS-0085,
NC00277,
NSC-759892,
RL04885,
VA11116,
Isopropyl Methyl 4-(4-Benzofurazanyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate,
KS-0000118G,
NCGC00025341-01,
NCGC00025341-02,
NCGC00025341-03,
NCGC00025341-06,
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-4-(4-benzofurazanyl)-2,6-dimethyl-, methyl 1-methylethyl ester, (+-)-,
3,5-Pyridinedicarboxylic acid, 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-, methyl 1-methylethyl ester (9CI),
4-(2,1,3-Benzooxadiazol-4-yl)-2.6-dimethyl-1,4-dihydro-3-isopropyloxycarbonylpyridine-5-carboxylic Acid Methyl Ester,
4-(4-Benzofurazanyl)-1,-4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid methyl 1-methhylethyl ester,
4-(4-Benzofurazanyl)-1,4-dihydro-2,-6-dimethyl-3,5-pyridinedicarboxylic acid methyl 1-methylethyl ester,
ACM131970213,
AK163124,
CPD002529690,
isopropyl 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-5-methoxycarbonyl-2,6-dimethyl-3-pyridinecarboxylate,
K297,
methyl 1-methylethyl 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate,
SAM001246584,
SC-16999,
AB2000202,
LS-131190,
LS-177211,
AB00514007,
FT-0627542,
I0876,
SW220017-1,
D00349,
AB00514007_02,
AB00514007_03,
695I931,
I06-0364,
J-513454,
SR-01000597526-1,
SR-01000597526-2,
BRD-A90799790-001-03-3,
BRD-A90799790-001-10-8,
DynaCirc;Prescal;PN-200-110;Clivoten;Esradin;Dynacirc,
Isradipine, European Pharmacopoeia (EP) Reference Standard,
Isradipine, United States Pharmacopeia (USP) Reference Standard,
Isopropyl Methyl 4-(2,1,3-Benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimet,
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-4-(4-benzofurazanyl)-2,6-dimethyl-,methyl 1-methylethyl ester, (+-)-,
3,5-Pyridinedicarboxylic acid, 4-(4-benzofurazanyl)-1,4-dihydro-2,6-dimethyl-, methyl 1-methylethyl ester, (.+/-.)-,
3-Isopropyl 5-methyl 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate #,
3-methyl 5-propan-2-yl 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate,
4-(2,1,3-Benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinecarboxylic acid methyl 1-methylethyl ester,
4-(4-Benzofurazanyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic Acid Isopropyl Methyl Ester,
Isopropyl methyl (.+/-.)-4-(4-benzfurazanyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate,
Isopropyl methyl (.+/-.)-4-(4-benzofurazanyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate,
O5-isopropyl O3-methyl 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate,
Prescal (TN),
Isradipine, (R)-Isomer,
Isradipine, (S)-Isomer,
PN-200, PharmaNova,
UNII-YO1UK1S598,
D0HC8Q,
D0Z7KE,
cc-164,
Isradipine [USAN:BAN:INN],
YO1UK1S598,
CID3784,
PN-200,
PN205033,
PN205034,
C19-H21-N3-O5,
Antiviral (genital herpes), PharmaNova,
CS-O-11671,
PN 205033,
PN 205034,
PN 205 033,
PN 205 034,
D017275,
DynaCirc, Prescal, PN-200-110, Clivoten, Esradin, Isradipine,
Isopropyl Methyl 4-(2,1,3-Benzoxadiazol-4-yl)-1,4-dihydro-2,6-dim,
131970-21-3,
3,5-Pyridinedicarboxylic acid, 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-, 3-methyl 5-(1-methylethyl) ester,
88977-22-4,
ESR,
|
| Complexity | 685 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 371.148g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 27 |
| Hydrogen Bond Acceptor Count | 8 |
| Hydrogen Bond Donor Count | 1 |
| Isotope Atom Count | 0 |
| Molecular Weight | 371.393g/mol |
| Monoisotopic Mass | 371.148g/mol |
| Rotatable Bond Count | 6 |
| Topological Polar Surface Area | 104A^2 |
| Undefined Atom Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 4.3 |
GHS Hazard and Precautionary Statements
| Symbol: | |
| Hazard statements | |
| Precautionary statements | |
Certificate of Analysis
Lot Number
Related Research Chemicals
CERTIFICATE OF ANALYSIS
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
Analysis Data:
| Test: | Result: |
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited